Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on June 25, 2025
Bryn Pharma Announces First Participant Dosed in PK/PD Trial with Upgraded Nasal Spray Device, Including First-of-Its-Kind, Two-Doses-in-One Nasal Spray Profile
GlobeNewswire
·
June 25, 2025
New clinical trial data with Bryn Pharma’s second-generation epinephrine nasal spray expected in Q3 2025 The trial employs an upgraded two-spray nasal spray device providing additional reliability and user experience enhancements Trial includes evaluation …
Media Advisory - Energy Sector Gains New Edge in Vegetation and Methane Emissions Monitoring with Maxar and Satelytics Partnership
GlobeNewswire
·
June 25, 2025
PERRYSBURG, Ohio, June 25, 2025 (GLOBE NEWSWIRE) -- Maxar and its partner Satelytics are announcing today an expansion of their offerings to the energy industry. In addition to the methane monitoring solution that has been on the market for several years, …
ORYZON to Host Virtual KOL Event on July 9, 2025
GlobeNewswire
·
June 25, 2025
MADRID and CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that it will host a virtual KOL event on …
Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
GlobeNewswire
·
June 25, 2025
Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package Includes Positive Results from Phase 3 STRIVE-ON Safety Trial of GTx-104 Submission Has the Potential to Trigger …
Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference
GlobeNewswire
·
June 25, 2025
REDWOOD CITY, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today highlighted new data on VYKATTM XR (diazoxide …
BigCommerce and Feedonomics Team Up with Perplexity to Help Brands Excel at AI Product Search
GlobeNewswire
·
June 25, 2025
AUSTIN, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading open SaaS ecommerce platform for B2C and B2B businesses, and Feedonomics, a leading data feed management solution, today announced their customers now have access to …
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
GlobeNewswire
·
June 25, 2025
SOUTH SAN FRANCISCO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. ( …
G2 Recognizes Regula as Identity Verification Leader with 100% Support Satisfaction
GlobeNewswire
·
June 25, 2025
RESTON, Va, June 25, 2025 (GLOBE NEWSWIRE) -- Regula, a global developer of forensic devices and identity verification solutions, has been recognized as a Leader in the G2 Grid® Report for Identity Verification | Summer 2025. Additionally, the company was …
Basecamp Research Announces Malawi Biodiscovery Partnership in Series of New Collaborations Across Three Continents at UK Government Nature Action Event
GlobeNewswire
·
June 25, 2025
Partnerships with Malawi, Hungary, and other new partners will rapidly expand BaseData, the largest biological protein database designed specifically for training generative AI foundation models to improve drug discovery and planetary health. …
DIMERx Awarded Up to $15M by NIDA Under NIH HEAL Initiative® to Advance DMX-101 as a Non-Addictive Oral Therapy for Chronic Pain
GlobeNewswire
·
June 25, 2025
SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage biopharmaceutical company entering growth phase, today announced it has been awarded a UG3/UH3 cooperative agreement (UG3DA061645) for up to $15 million from the National Institute …
For mining novices: PBKMiner launches free BTC, ETH, DOGE and XRP cloud mining services
GlobeNewswire
·
June 25, 2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- The global cryptocurrency market has entered a new era of acceptance and legitimacy following the US government’s landmark decision to establish a strategic Bitcoin reserve in March 2025. Riding on this …
Gero Launches ProtoBind-Diff, a Structure-Free AI Foundation Model for Targeted Small Molecule Discovery
GlobeNewswire
·
June 25, 2025
ProtoBind-Diff generates drug-like molecules for specific protein targets using only their amino acid sequences—no 3D structures required. The model performs competitively with leading structure-based tools in predicting binding strength, while also …
XRP Mining Launches New Cloud Mining App for Global Users
GlobeNewswire
·
June 25, 2025
San Francisco, California, June 25, 2025 (GLOBE NEWSWIRE) -- With the rapid development of the digital financial world, cryptocurrency has become a global focus. However, it is difficult for ordinary people to succeed in this field. Traditional …
BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System
GlobeNewswire
·
June 25, 2025
SUNNYVALE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the United States Patent Office …
Report: 1 in 2 Employees Have Excessive Privileged Access—CloudEagle.ai Survey Warns of Escalating Insider Risk due to AI and SaaS Sprawl
GlobeNewswire
·
June 25, 2025
PALO ALTO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- A new report from CloudEagle.ai, the AI-powered SaaS management and governance platform, reveals that 60% of enterprise SaaS and AI applications now operate outside IT's visibility. This surge in “ …
ImmuCell Embarks on CEO Succession Planning Process
GlobeNewswire
·
June 25, 2025
PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
GlobeNewswire
·
June 25, 2025
MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo data for investigational oral OPK-88006 tablet treatment …
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
GlobeNewswire
·
June 25, 2025
NEW YORK and STOCKHOLM, Sweden, June 25, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced that it …
BIO-key Joins ISMS Forum to Advance Cybersecurity and Identity Management Best Practices in Spain
GlobeNewswire
·
June 25, 2025
MADRID and HOLMDEL, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced that it has joined ISMS Forum, Spain’s …
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
GlobeNewswire
·
June 25, 2025
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: …